Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Response, Acute Phase”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01786343
What this trial is testing

Decitabine for Older or Unfit Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 74
Testing effectiveness (Phase 2)Looking for participantsNCT07215702
What this trial is testing

Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.

Who this might be right for
SepsisAcute Kidney Injury
AstraZeneca 124
Early research (Phase 1)Not Yet RecruitingNCT07166549
What this trial is testing

Bispecific CAR T Cells for B-cell Malignancies (BaseCAR-01 Trial)

Who this might be right for
B Cell MalignanciesB-cell LeukemiaB Cell Lymphoma+2 more
University Hospital, Basel, Switzerland 12
Post-approval studies (Phase 4)Study completedNCT05561725
What this trial is testing

Perioperative Steroid Dosing on the APR in AIS

Who this might be right for
Adolescent Idiopathic Scoliosis (AIS)
Emory University 42
Testing effectiveness (Phase 2)Study completedNCT00005606
What this trial is testing

Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Northwestern University
Testing effectiveness (Phase 2)Study completedNCT00012467
What this trial is testing

Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis

Who this might be right for
Meningitis, CryptococcalHIV Infections
InterMune 60
Post-approval studies (Phase 4)Looking for participantsNCT06881927
What this trial is testing

Eduction in ImmunoSuppressive Regimen Among Kidney Transplant Recipients Patients Admitted to the Intensive Care Unit for Septic Shock and/or Acute Respiratory Failure

Who this might be right for
Sepsis and Septic ShockAcute Respiratory FailureKidney Transplant Recipients+1 more
University Hospital, Strasbourg, France 212
Not applicableLooking for participantsNCT06284395
What this trial is testing

Two Schemes Response in Multiple Myeloma

Who this might be right for
Response, Acute PhaseSurvivorship
Hospital General de Mexico 83
Large-scale testing (Phase 3)Study completedNCT01863186
What this trial is testing

Efficacy, Safety and Dose-Response Study Followed by Open-Label Study of Lofexidine Treatment of Opioid Withdrawal

Who this might be right for
Opioid DependenceAcute Opioid Withdrawal Syndrome
USWM, LLC (dba US WorldMeds) 603
Not applicableStudy completedNCT06298513
What this trial is testing

Autonomic and Metabolic Response to Cardiac Rehabilitation After Acute MI

Who this might be right for
Acute Myocardial Infarction: Rehabilitation Phase
Istituto Auxologico Italiano 25
Large-scale testing (Phase 3)Study completedNCT01743989
What this trial is testing

Phase III Study to Assess the Effect of a Longer Duration of Consolidation Treatment With Nilotinib on TFR in CP CML.

Who this might be right for
Philadelphia Chromosome Positive (PH+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
Novartis Pharmaceuticals 620
Not applicableStudy completedNCT02860572
What this trial is testing

Non-interventional Follow-up Versus Fluid Bolus in RESPONSE to Oliguria in the Critically Ill

Who this might be right for
Critically IllAcute Kidney InjurySepsis+1 more
Helsinki University Central Hospital 130
Large-scale testing (Phase 3)Not Yet RecruitingNCT07550894
What this trial is testing

Phosphate-Containing Replacement Fluid for Patients Undergoing CRRT

Who this might be right for
Acute Kidney InjurySepsisCritically Ill Patients Requiring Continuous Renal Replacement Therapy
Sun Yat-sen University 220
Testing effectiveness (Phase 2)Active Not RecruitingNCT01686334
What this trial is testing

Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission

Who this might be right for
Acute Myeloid Leukemia
Zwi Berneman 130
Post-approval studies (Phase 4)UnknownNCT00484965
What this trial is testing

Erythrocyte-Mediated Drug Delivery for the Prevention of Stent Restenosis

Who this might be right for
AtherosclerosisAcute-Phase Reaction
University of Rome Tor Vergata 100
Testing effectiveness (Phase 2)Study completedNCT03202394
What this trial is testing

Evaluation of Safety & Efficacy of BIO-11006 Inhalation Solution in Patients With ARDS

Who this might be right for
Respiratory Distress Syndrome, Adult
BioMarck Pharmaceuticals, Ltd. 38
Not applicableUnknownNCT05656339
What this trial is testing

Metabolic Effects of Whey Protein Supplementation After Fasting in Volunteers

Who this might be right for
KetosisAcute-Phase ResponseInsulin Resistance
Federal University of Mato Grosso 30
Testing effectiveness (Phase 2)UnknownNCT03145220
What this trial is testing

Immunomodulation of EA-230 Following On-pump Coronary Artery Bypass Grafting (CABG)

Who this might be right for
Systemic Inflammatory Response SyndromeCoronary Artery Bypass Grafting
Radboud University Medical Center 180
Testing effectiveness (Phase 2)Study completedNCT02550535
What this trial is testing

A Phase I/II Study of Gene-modified WT1 TCR Therapy in MDS & AML Patients

Who this might be right for
Myelodysplastic Syndromes (MDS)Acute Myeloid Leukaemia (AML)
Cell Medica Ltd 3
Testing effectiveness (Phase 2)Ended earlyNCT00276159
What this trial is testing

Study of Immune Response Modifier in the Treatment of Hematologic Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaNon-Hodgkin's Lymphoma+3 more
Masonic Cancer Center, University of Minnesota 6
Next Page